IL33 and nervous system disorder: Thus, the IL-33/ST2 signaling pathway may contribute to the cognitive impairment typical of neurological diseases at least in part by promoting the proliferation, recruitment, and activation of astrocytes and microglia, which release pro-inflammatory cytokines.